Product Information
HYDROMORPHONE 5 MG/5 ML SOLN is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.2359 per ML under NDC 42858030416. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 7, 1992. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858030416
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019891FDA Approved
12/7/1992
TE Code
AA
On Market Since
7/20/2012
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 5 MG/5 ML SOLN has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2359 per ML |
|---|---|
| All-time high | $0.4064 (Oct 12, 2016) |
| All-time low | $0.2058 (Mar 22, 2023) |
| 52-week high | $0.3015 |
| 52-week low | $0.2359 |
| Median price | $0.2842 |
| Average price | $0.2796 |
| Largest weekly change | +39.4% (Jun 21, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydromorphone Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rhodes Pharmaceuticals L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydromorphone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 5 MG/5 ML SOLN, manufactured by Rhodes Pharmaceuticals L.P., is $0.2359 per ML (NDC 42858030416), effective Sep 30, 2026.
How has the price of HYDROMORPHONE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 5 MG/5 ML SOLN has declined 20.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 5 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for HYDROMORPHONE 5 MG/5 ML SOLN has ranged from a low of $0.2058 (Mar 22, 2023) to a high of $0.4064 (Oct 12, 2016), with a median of $0.2842 per ML.
Are there cheaper alternatives to HYDROMORPHONE 5 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE 5 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 5 MG/5 ML SOLN?
HYDROMORPHONE 5 MG/5 ML SOLN (NDC 42858030416) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.